Phio Pharmaceuticals Corp.
PHIO· Nasdaq
Released Aug 14, 2024, after the close
10-Q filed Aug 14, 2024, 45 days after period end · 0001683168-24-005706
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$1.85M | -$2.55M | -$2.53M | -$2.69M |
| EPS Diluted | -$3.62 | -$13.27 | -$2.22 | -$0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR